TM
LXEO icon

Torren Management’s Lexeo Therapeutics LXEO Stock Holding History

Torren Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829 Hold
178
– – ﹤0.01% 771
2026
Q1 		$1.02K Sell
178
-143
-45% -$1.01K ﹤0.01% 738
2025
Q4 		$3.19K Buy
+321
New +$2.93K ﹤0.01% 984

Other funds holding LXEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Torren Management's LXEO Position: Q2 2026 in Review

Torren Management held its Lexeo Therapeutics (LXEO) position steady in Q2 2026 at 178 shares worth $829. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Torren Management first reported a position in LXEO in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.19K in Q4 2025. 37 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Torren Management held 178 shares of Lexeo Therapeutics worth $829 as of Q2 2026.
  • Torren Management left its Lexeo Therapeutics share count unchanged in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #771 holding.
  • Torren Management first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Lexeo Therapeutics position peaked at $3.19K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.